| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/17/2003 | US20030072780 Cosmetic or pharmaceutical compositions for topical application to skin |
| 04/17/2003 | US20030072764 Mucosal boosting following parenteral priming |
| 04/17/2003 | US20030072763 Absorb in the low- energy, ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum that are used for the phototherapy of tumors and other lesions |
| 04/17/2003 | US20030072753 Virus-like particles for the induction of autoantibodies |
| 04/17/2003 | US20030072749 Applying at least one chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve for promoting repair of a damaged nerve |
| 04/17/2003 | US20030072740 Pulmonary delivery of active agents |
| 04/17/2003 | US20030072729 Simethicone as weight gain enhancer |
| 04/17/2003 | US20030072724 Topical pharmaceutical composition to treat hyperpigmentation of the skin |
| 04/17/2003 | US20030072718 Spray drying to produce stable, high-potency dry powder formulations; utility in pulmonary delivery of interferons |
| 04/17/2003 | US20030070903 Systems, methods and apparatuses for manufacturing dosage forms |
| 04/17/2003 | US20030070687 Encapsulated materials |
| 04/17/2003 | US20030070584 Dip coating compositions containing cellulose ethers |
| 04/17/2003 | DE10135356C1 Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen Macrocyclic metal complexes and their use for the preparation of conjugates with biomolecules |
| 04/17/2003 | DE10135355C1 Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie Conjugates of macrocyclic metal complexes with biomolecules and their use for the preparation of agents for NMR and Radiology and Radiotherapy |
| 04/17/2003 | CA2788500A1 Modifications of solid 3-sn-phosphoglycerides |
| 04/17/2003 | CA2473970A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 04/17/2003 | CA2463384A1 Hydrating nasal gel and applicator |
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | CA2462886A1 Flashmelt oral dosage formulation |
| 04/17/2003 | CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/17/2003 | CA2462582A1 Adjuvants for nucleic acid vaccines |
| 04/17/2003 | CA2462579A1 Use of tazarotene for preparing a nail varnish for treating and/or preventing psoriasis and nail varnish containing same |
| 04/17/2003 | CA2461900A1 Leukocyte inactivation module |
| 04/17/2003 | CA2461048A1 Liposome-encapsulated insulin formulations |
| 04/17/2003 | CA2458473A1 Pharmaceutical formulation |
| 04/17/2003 | CA2458464A1 Monoclonal and cdr-grafted antibodies specific for human kdr |
| 04/17/2003 | CA2458392A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 04/16/2003 | WO2003032915A2 Viral inhibition by n-docosanol |
| 04/16/2003 | EP1302477A1 Peptide fructose and complex thereof with binding protein |
| 04/16/2003 | EP1302205A1 Controlled release formulations of macrolide citrate salts |
| 04/16/2003 | EP1302201A1 Pharmaceutical composition improved in peroral absorbability |
| 04/16/2003 | EP1302200A1 Pharmaceutical formulation of a budesonide-containing water-propylene glycol solution and method of preparing it |
| 04/16/2003 | EP1301638A1 Method for producing a crystalline tableting additive, additive thus obtained and use thereof |
| 04/16/2003 | EP1301614A1 Codon-optimized papilloma virus sequences |
| 04/16/2003 | EP1301540A2 Rgd (arg-gly-asp) coupled to neuropeptides |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 04/16/2003 | EP1301238A1 Vaccines |
| 04/16/2003 | EP1301215A1 Radioactive compositions and methods of use thereof |
| 04/16/2003 | EP1301213A2 Multi-component biological transport systems |
| 04/16/2003 | EP1301212A1 Pharmaceutically active compound |
| 04/16/2003 | EP1301211A2 Multifunctional nanodevice platform |
| 04/16/2003 | EP1301210A2 Compositions containing therapeutically active components having enhanced solubility |
| 04/16/2003 | EP1301209A1 Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
| 04/16/2003 | EP1301207A2 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin |
| 04/16/2003 | EP1301200A2 Peptide pharmaceutical formulations |
| 04/16/2003 | EP1301196A2 Stimulation of bone growth with thrombin peptide derivatives |
| 04/16/2003 | EP1301181A2 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds |
| 04/16/2003 | EP1301179A2 Transdermal therapeutic system for highly dispersed silicon dioxide |
| 04/16/2003 | EP1301176A1 Method for coating solid particles with a thermofusible agent, and resulting coated solid particles |
| 04/16/2003 | EP1301175A2 Suppository and composition comprising at least one polyethylene glycol |
| 04/16/2003 | EP1301173A1 A medicinal aerosol formulation |
| 04/16/2003 | EP1301168A1 Storage-stable compositions of glycerol monoalkyl ethers |
| 04/16/2003 | EP1301150A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 04/16/2003 | EP1301075A1 Modified serum albumin with reduced affinity for nickel and copper |
| 04/16/2003 | EP1185254B1 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 04/16/2003 | EP1181047B1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/16/2003 | EP1121100B1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 04/16/2003 | EP1105099B1 Fish gelatinous composition for use as an ingredient in tablets |
| 04/16/2003 | EP1104288A4 Orally disintegrable tablet forming a viscous slurry |
| 04/16/2003 | EP1100472B1 Pharmaceutical compositions comprising ibuprofen and domperidone |
| 04/16/2003 | EP1096921B1 Liposomal encapsulated nucleic acid-complexes |
| 04/16/2003 | EP1051156B1 Pharmaceutical compositions |
| 04/16/2003 | EP1043986B1 Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin |
| 04/16/2003 | EP1028718B1 Extended release formulation containing venlafaxin |
| 04/16/2003 | EP0977565B1 Pharmaceutical composition comprising a tricyclic compound with enhanced stability, absorbability and low irritation potential |
| 04/16/2003 | EP0920337B1 Use of inorganic aerogels in pharmacy |
| 04/16/2003 | EP0904055B1 Buccal, non-polar spray or capsule |
| 04/16/2003 | EP0893998B1 Colonic delivery of nicotine to treat inflammatory bowel disease |
| 04/16/2003 | EP0885016B1 Thermally stabilized contrast agent |
| 04/16/2003 | EP0806942B1 Starch acetate composition with modifiable properties, method for preparation and usage thereof |
| 04/16/2003 | EP0801554B1 Formulations and methods for reducing skin irritation |
| 04/16/2003 | EP0773955B1 New thrombin inhibitors, their preparation and use |
| 04/16/2003 | EP0680338B1 Ganglioside-klh conjugate vaccines with qs-21 |
| 04/16/2003 | EP0648271B1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/16/2003 | EP0577817B2 Water-in-oil emulsion stable in the course of time, with high silicone content |
| 04/16/2003 | CN1411512A Chimeric immunogenic compositions and nucleir acids encoding them |
| 04/16/2003 | CN1411467A Compounds and use thereof to modify transport across cell membranes |
| 04/16/2003 | CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 04/16/2003 | CN1411424A Electrolysis purifying of calcium carbonate |
| 04/16/2003 | CN1411388A Methods for extraction and reaction using supercritical fluids |
| 04/16/2003 | CN1411380A Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
| 04/16/2003 | CN1411376A Novel helicobacter pylori-binding substances and use thereof |
| 04/16/2003 | CN1411372A Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 04/16/2003 | CN1411371A Compressed microparticles for dry injection |
| 04/16/2003 | CN1411369A Biodegradable microparticles with novel erythropoietin stimulating protein |
| 04/16/2003 | CN1411368A Method for producing liposome preparation |
| 04/16/2003 | CN1411367A Suspension comprising oxcarbazepine |
| 04/16/2003 | CN1411347A Composition for improving proliferative response during adapation of gastrointestinal tract and use in short bowel syndrome |
| 04/16/2003 | CN1411337A Anthelmintic compositions |
| 04/16/2003 | CN1411335A Fluid insecticidal formulations for dermal treatment of parasitic insect larvae |
| 04/16/2003 | CN1410461A (Methyl) hydroxyalkyl acrylate (co) polymer, preparing process and its use |
| 04/16/2003 | CN1409995A Synthetic sweetener |
| 04/16/2003 | CN1105705C Process for preparing heterocyclic amide derivative with specific physical status |
| 04/16/2003 | CN1105576C Insulin analog formulation |
| 04/16/2003 | CN1105557C Sustained releasable parenteral pharmaceutical preparations and method of producing same |
| 04/16/2003 | CN1105551C Aqueous product comprising stable oil microdroplets and producing method thereof |
| 04/15/2003 | US6548717 Via dimerization then esterification of fatty acid, then hydrogenating fatty esters; for production of surfactants; improved autooxidation stability |
| 04/15/2003 | US6548687 Chromium L-threonate, process for preparation of the same and their use |
| 04/15/2003 | US6548651 Modified peptide nucleic acid (PNA) molecules |